Founded in 2008 as a spin-off from the lab of proteomics pioneer Ruedi Aebersold at ETH Zurich, Biognosys today is an established leader in next-generation proteomics. From our global headquarters just outside of Zurich, we operate one of the largest proteomics facilities in the world. Through our global presence across Switzerland, Europe, and the US, and our extensive network of collaborators and distributors, we make the most advanced proteomics solutions available to life science researchers across industry and academia.
We are inventors. We push the boundaries of what is possible to drive new discoveries.
We build enduring partnerships because our name is only as good as the quality of what we deliver.
We address our partners needs with dedication and speed to offer the best possible value for their research.
We deliver proteomics insights that are actionable in the quest to improve human health.
Biognosys’ patented next generation proteomics technology utilizes high-resolution mass spectrometry to quantify proteins with high precision and depth. Our proprietary solutions equip researchers from all fields with a multi-dimensional view of protein expression, function, and structure in all major sample types – cells, tissues, or body fluids – across human and non-human species. Through advanced data analytics, we translate data into actionable insights for R&D and clinical research.
With market-leading proteome coverage and sample throughput, we enable simultaneous quantification of thousands of proteins across thousands of samples.
Access posters, seminars, white papers, videos and other content to fast-track proteomics insights for your research.
Access our knowledge base with relevant resources and guiding information.